LASD reports 20% increase in nine-month net profit

February 10, 2023

 

Revenue for the nine months ended December 31, 2022 increased 13% to $19.64 billion (2021: $17.37 billion). Management noted that this resulted because of growth in both Domestic and Export markets. Revenue for the quarter increased 17% to $6.78 billion (2021: $5.79 billion).

Cost of Sales for the nine months ended December 31, 2022 increased 12% to $16.23 billion (2021: $14.45 billion). for the quarter cost of Sales increased 17% to $5.59 billion (2021: $4.79 billion).

Gross Profit for the nine months ended December 31, 2022 increased 17% to $3.41 billion (2021: $2,92 billion). Gross Profit for the quarter improved 19% year over year to $1.19 billion (2021: $1 billion).

Other Operating Income for the nine-month period decreased 18% to $161.23 million (2021: $196.59 million).

Operating Expenses year to date increased 11% to $2.37 billion (2021: $2.13 billion), while for the quarter there was an increase of 7% to $800.21 million (2021: $751.37 million).

Profit from Operations for the nine months ended December 31, 2022 increased 23% to $1.20 billion (2021: $979.18 million). Profit from Operations for the quarter increased 32% to $480.71 million (2021: $362.96 million).

Finance Costs for the nine months ended December 31, 2022 reflected a surged to $24.72 million relative to $1.52 million for the corresponding period in 2021.

Profit Before Taxation for the nine months ended December 31, 2022 increased 20% to $1.18 billion (2021: $977.66 million). Profit Before Taxation for the quarter increased 26% to $457.31 million (2021: $362.60 million).

LASD recorded Taxation for the nine months ended December 31, 2022 of $245.42 million (2021: $202.46 billion).

Net Profit for the nine months ended December 31, 2022 increased 20% to $930.11 million (2021: $775.20 million). Net Profit for the quarter increased 20% to $342.98 million (2021: $285.90 million).

Total Comprehensive Income for the nine months ended December 31, 2022 increased 22% to $963.57 million (2021: $790.43 million). Total Comprehensive Income for the quarter increased 13% to $340.35 million (2021: $301.13 million).

Earnings per Share (EPS) for the nine months ended December 31, 2022 was $0.26 (2021: $0.22). EPS for the quarter ended December 31, 2022 was $0.10 (2021: $0.08). The twelve-month trailing earnings per share amounted to $0.33. The number of shares outstanding used for this calculation was 3,510,702,702. LASD’s stock closed the trading period at a price of $2.78 on February 8, 2023 with a corresponding P/E ratio of 8.33 times.

Management noted that “the focus on Exports continues to deliver above company average growth, in line with the company’s strategic objectives.”

Balance Sheet at a glance:

As at December 31, 2022, the Company’s total assets closed at $12.50 billion, 7% more than the $11.65 billion quoted a year ago. The main contributor to this was the 33% increase in ‘Inventories’, which closed at $4.40 billion (2021: $3.29 billion) tempered by a 47% decline in ‘Cash and Cash Equivalent’, which closed at $1.21 billion (2021: $2.27 billion).

Shareholders’ Equity stood at $7.90 billion (2021: $7.03 billion), resulting in a book value per share of $2.25 (2021: $2.00).

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein

More Stories from the Market
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…
shutterstock_453968572
March 24, 2026   Kintyre Holdings (JA) Limited (KNTYR) has advised that Visual Vibe Limited has entered into a strategic partnership with K…
shutterstock_148562033
March 24, 2026   Sagicor Group Jamaica Limited (SJ) has advised that an Executive sold 5,000 SJ shares on March 23, 2026.   Di…
shutterstock_148562033
March 24, 2026   JMMB Group Limited (JMMBGL) has advised of the purchase of 49,705 JMMBGL shares on March 19, 2026, under the Company’s sha…
shutterstock_453968572
March 24, 2026   A.S. Bryden & Sons Holdings Limited (ASBH) has advised of the appointment of Mr. John De Silva to the position of Grou…
shutterstock_453968572
March 24, 2026   United States: US Business Activity Growth Cools as Prices Rise on Iran War   Growth in US business activity slow…
shutterstock_453968572
March 23, 2026   Sagicor Real Estate X Fund Limited (XFUND) has advised that the Board of Directors intends to convene a meeting on Monday,…